To asses mid-term clinical outcomes of bioresorbable vascular scaffolds (BVS) for the treatment of coronary artery disease in a large-scale all-comers population.
Outcomes of 10,312 patients treated with everolimus-eluting bioresorbable scaffolds during daily clinical practice - results from the European Absorb Consortium
Tarantini, Giuseppe;
2021
Abstract
To asses mid-term clinical outcomes of bioresorbable vascular scaffolds (BVS) for the treatment of coronary artery disease in a large-scale all-comers population.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Cathet Cardio Intervent - 2021 - Wiebe - Outcomes of 10 312 patients treated with everolimus‐eluting bioresorbable.pdf
accesso aperto
Tipologia:
Published (Publisher's Version of Record)
Licenza:
Creative commons
Dimensione
226.66 kB
Formato
Adobe PDF
|
226.66 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
